Please provide your email address to receive an email when new articles are posted on . An epithelium-on cross-linking procedure from Glaukos delivers oxygen to the eye during treatment. In a study, ...

In this exclusive interview with Healio, Cosimo Mazzotta, MD, PhD, one of the pioneers of corneal cross-linking, reverses the ...

Credit: Glaukos. Epioxa does not require the removal of the corneal epithelium, a step usually required by traditional corneal cross-linking procedures, thereby minimizing pain and recovery time.

Epioxa Provides the Ophthalmic Community and Patients with the First and Only FDA-Approved, Incision-Free, Topical Drug Therapy for Keratoconus Epioxa Represents a Novel, Groundbreaking Therapy for ...

Glaukos Corporation announced that the US Centers for Medicare and Medicaid Services (CMS) has assigned a permanent ...

Patients in Somerset with keratoconus, an eye condition that causes blurred vision and sensitivity to light, can now access ...